As the results shown in Figure 1, the expression levels of AQP4, CLDN18, FOXA2, NKX2-1, PGC, SFTPB, SFTPC, and SFTPD were all remarkably reduced in lung cancer vs. normal tissues in multiple datasets. This evidence concerns the gene SFTPD and lung cancer.